Hypoxia activates Wnt/β-catenin signaling by regulating the expression of BCL9 in human hepatocellular carcinoma
Open accessThe DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Abstract
The Wnt/β-catenin signaling is abnormally activated in the progression of hepatocellular carcinoma (HCC). BCL9 is an essential co-activator in the Wnt/β-catenin signaling. Importantly, BCL9 is absent from tumors originating from normal cellular counterparts and overexpressed in many cancers including HCC. But the mechanism for BCL9 overexpression remains unknown. Ample evidence indicates that hypoxia inducible factors (HIFs) play a role in the development of HCC. It was found in our study that BCL9 was overexpressed in both primary HCC and bone metastasis specimens; loss of BCL9 inhibited the proliferation, migration and angiogenesis of HCC; and that that hypoxia mechanically induced the expression of BCL9. BCL9 induction under the hypoxic condition was predominantly mediated by HIF-1α but not HIF2α. In vitro evidence from xenograft models indicated that BCL9 promoter/gene knockout inhibited HCC tumor growth and angiogenesis. Notably, we found that BCL9 and HIF-1α were coordinately regulated in human HCC specimen. The above findings suggest that hypoxia may promote the expression of BCL9 and associate with the development of HCC. Specific regulation of BCL9 expression by HIF-1α may prove to be an underlying crosstalk between Wnt/β-catenin signaling and hypoxia signaling pathways.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Conversely, recent studies have demonstrated that bilirubin possesses signalling properties that can activate HIF and Wnt signalling cascades3,57, which are important for pericentral hepatocytes58.”
From Multi-zonal liver organoids from human pluripotent stem cells (2025) · cites this paper as [57]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wnt/β-Catenin Signaling in Development and Disease
Clevers, H. (2006) · Cell · doi:10.1016/j.cell.2006.10.018 · Cited by 5,568
Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis
El–Serag, H. B., & Rudolph, K. L. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.04.061 · Cited by 5,415
Hypoxia — a key regulatory factor in tumour growth
Harris, A. L. (2002) · Nature Reviews Cancer · doi:10.1038/nrc704 · Cited by 5,177 · cited 1×
“Hypoxia is a common feature of all solid tumors and plays an essential role in tumor occurrence and development 16 .”
Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients
Locatelli, F., Fishbane, S., Block, G. A., & Macdougall, I. C. (2017) · American Journal of Nephrology · doi:10.1159/000455166 · Cited by 4,813
Identification of c- MYC as a Target of the APC Pathway
He, T.-C., Sparks, A. B., Rago, C., Hermeking, H., Zawel, L., da Costa, L. T., Morin, P. J., Vogelstein, B., & Kinzler, K. W. (1998) · Science · doi:10.1126/science.281.5382.1509 · Cited by 4,566
β-Catenin regulates expression of cyclin D1 in colon carcinoma cells
Tetsu, O., & McCormick, F. (1999) · Nature · doi:10.1038/18884 · Cited by 3,601
Primary carcinoma of the liver.A study of 100 cases among 48,900 necropsies
Edmondson, H. A., & Steiner, P. E. (1954) · Cancer · doi:10.1002/1097-0142(195405)7:3<462::aid-cncr2820070308>3.0.co;2-e · Cited by 2,772
Hypoxia in cancer: significance and impact on clinical outcome
Vaupel, P., & Mayer, A. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9055-1 · Cited by 2,240
Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling
Huang, S.-M. A., Mishina, Y. M., Liu, S., Cheung, A., Stegmeier, F., Michaud, G. A., Charlat, O., Wiellette, E., Zhang, Y., Wiessner, S., et al. (2009) · Nature · doi:10.1038/nature08356 · Cited by 2,037
HIF-1α pathway: role, regulation and intervention for cancer therapy
Masoud, G. N., & Li, W. (2015) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2015.05.007 · Cited by 1,871 · cited 1×
“In addition, the difference in HIF1 α and HIF2 α gene selection can be attributed to their interactions with different transcription factors and/or chromatin context 42,43 .”
HIF1α and HIF2α: sibling rivalry in hypoxic tumour growth and progression
Keith, B., Johnson, R. S., & Simon, M. C. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3183 · Cited by 1,693
Wnt signalling and its impact on development and cancer
Klaus, A., & Birchmeier, W. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2389 · Cited by 1,595 · cited 1×
“…by the destruction complex consisting of adenomatous polyposis coli (APC), Axin, glycogen synthase kinase-3 β (GSK3 β ), and casein kinase 1 α 4,5 , while in the presence of Wnt ligands, this destruction complex is dissociated and the unphosphorylated active β -catenin continuously accumulates…”
Differential Roles of Hypoxia-Inducible Factor 1α (HIF-1α) and HIF-2α in Hypoxic Gene Regulation
Hu, C.-J., Wang, L.-Y., Chodosh, L. A., Keith, B., & Simon, M. C. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.24.9361-9374.2003 · Cited by 1,386
HIF-1 and mechanisms of hypoxia sensing
Semenza, G. L. (2001) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(00)00194-0 · Cited by 1,268
Links between metabolism and cancer
Dang, C. V. (2012) · Genes & Development · doi:10.1101/gad.189365.112 · Cited by 1,100
Ema, M., Taya, S., Yokotani, N., Sogawa, K., Matsuda, Y., & Fujii-Kuriyama, Y. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.9.4273 · Cited by 1,016
Covello, K. L., Kehler, J., Yu, H., Gordan, J. D., Arsham, A. M., Hu, C.-J., Labosky, P. A., Simon, M. C., & Keith, B. (2006) · Genes & Development · doi:10.1101/gad.1399906 · Cited by 821
The role of hypoxia-inducible factors in tumorigenesis
Rankin, E. B., & Giaccia, A. J. (2008) · Cell Death & Differentiation · doi:10.1038/cdd.2008.21 · Cited by 806
Kramps, T., Peter, O., Brunner, E., Nellen, D., Froesch, B., Chatterjee, S., Murone, M., Züllig, S., & Basler, K. (2002) · Cell · doi:10.1016/s0092-8674(02)00679-7 · Cited by 561
Miyoshi, Y., Iwao, K., Nagasawa, Y., Aihara, T., Sasaki, Y., Imaoka, S., Murata, M., Shimano, T., & Nakamura, Y. (1998) · PubMed · Cited by 514
O2 regulates stem cells through Wnt/β-catenin signalling
Mazumdar, J., O'Brien, W. T., Johnson, R. S., LaManna, J. C., Chavez, J. C., Klein, P. S., & Simon, M. C. (2010) · Nature Cell Biology · doi:10.1038/ncb2102 · Cited by 454
Zhang, T., Otevrel, T., Gao, Z., Gao, Z., Ehrlich, S. M., Fields, J. Z., & Boman, B. M. (2001) · PubMed · Cited by 441
Hu, C.-J., Sataur, A., Wang, L., Chen, H., & Simon, M. C. (2007) · Molecular Biology of the Cell · doi:10.1091/mbc.e06-05-0419 · Cited by 355
Skuli, N., Liu, L., Runge, A., Wang, T., Yuan, L., Patel, S., Iruela-Arispe, L., Simon, M. C., & Keith, B. (2009) · Blood · doi:10.1182/blood-2008-12-193581 · Cited by 255
Zhang, Q., Bai, X., Chen, W., Ma, T., Hu, Q., Liang, C., Xie, S., Chen, C., Hu, L., Xu, S., et al. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt027 · Cited by 248
Targeted Disruption of the BCL9/β-Catenin Complex Inhibits Oncogenic Wnt Signaling
Takada, K., Zhu, D., Bird, G. H., Sukhdeo, K., Zhao, J.-J., Mani, M., Lemieux, M., Carrasco, D. E., Ryan, J., Horst, D., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003808 · Cited by 245
Self-citationCommon dysregulation of Wnt/Frizzled receptor elements in human hepatocellular carcinoma
Bengochea, A., de Souza, M. M., Lefrançois, L., Le Roux, E., Galy, O., Chemin, I., Kim, M., Wands, J. R., Trepo, C., Hainaut, P., et al. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604422 · Cited by 215 · cited 1×
“It was reported that the Wnt/ β -catenin signaling pathway was activated at least 95% HCC patients 48 .”
Hypoxia and hepatocellular carcinoma: The therapeutic target for hepatocellular carcinoma
Wu, X., Xie, G., & Chen, D. (2007) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2007.04997.x · Cited by 212
Townsley, F. M., Cliffe, A., & Bienz, M. (2004) · Nature Cell Biology · doi:10.1038/ncb1141 · Cited by 209
Mani, M., Carrasco, D. E., Zhang, Y., Takada, K., Gatt, M. E., Dutta-Simmons, J., Ikeda, H., Diaz-Griffero, F., Pena-Cruz, V., Bertagnolli, M., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0773 · Cited by 185
Zhao, J.-J., Lin, J., Zhu, D., Wang, X., Brooks, D., Chen, M., Chu, Z.-B., Takada, K., Ciccarelli, B., Admin, S., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-3311-t · Cited by 177
HIF Hydroxylase Pathways in Cardiovascular Physiology and Medicine
Bishop, T., & Ratcliffe, P. J. (2015) · Circulation Research · doi:10.1161/circresaha.117.305109 · Cited by 169
HIF-1 versus HIF-2 — Is one more important than the other?
Loboda, A., Jozkowicz, A., & Dulak, J. (2012) · Vascular Pharmacology · doi:10.1016/j.vph.2012.02.006 · Cited by 152 · cited 1×
“Although HIF-1 α and HIF-2 α induce a number of common genes, and at the same time they have their respective unique target genes 40,41 .”
Hypoxia Drives Breast Tumor Malignancy through a TET–TNFα–p38–MAPK Signaling Axis
Wu, M.-Z., Chen, S.-F., Nieh, S., Benner, C., Ger, L.-P., Jan, C.-I., Ma, L., Chen, C.-H., Hishida, T., Chang, H.-T., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-3208 · Cited by 137
Menrad, H., Werno, C., Schmid, T., Copanaki, E., Deller, T., Dehne, N., & Brüne, B. (2010) · Hepatology · doi:10.1002/hep.23597 · Cited by 132
HIF-2α deletion promotes Kras-driven lung tumor development
Mazumdar, J., Hickey, M. M., Pant, D. K., Durham, A. C., Sweet-Cordero, A., Vachani, A., Jacks, T., Chodosh, L. A., Kissil, J. L., Simon, M. C., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1001296107 · Cited by 130
Interplay between VHL/HIF1α and Wnt/β-catenin pathways during colorectal tumorigenesis
Giles, R. H., Lolkema, M. P., Snijckers, C. M. J. T., Belderbos, M. E., van der Groep, P., Mans, D. A., van Beest, M., van Noort, M., Goldschmeding, R., van Diest, P. J., et al. (2005) · Oncogene · doi:10.1038/sj.onc.1209330 · Cited by 118
The function of BCL9 in Wnt/β-catenin signaling and colorectal cancer cells
de la Roche, M., Worm, J., & Bienz, M. (2008) · BMC Cancer · doi:10.1186/1471-2407-8-199 · Cited by 108
Hypoxia-inducible factor 1 and its role in viral carcinogenesis
Cuninghame, S., Jackson, R., & Zehbe, I. (2014) · Virology · doi:10.1016/j.virol.2014.02.027 · Cited by 79
Sun, H.-X., Xu, Y., Yang, X.-R., Wang, W.-M., Bai, H., Shi, R.-Y., Nayar, S. K., Devbhandari, R. P., He, Y.-Z., Zhu, Q.-F., et al. (2013) · Hepatology · doi:10.1002/hep.26188 · Cited by 79
WNT/β-catenin signaling and hepatocellular carcinoma
Wands, J. R., & Kim, M. (2014) · Hepatology · doi:10.1002/hep.27081 · Cited by 73
Jia, W. P., Eneh, J. O., Ratnaparkhe, S. M., Altman, M. K., & Murph, M. M. (2011) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-11-0245 · Cited by 71
Sustmann, C., Flach, H., Ebert, H., Eastman, Q., & Grosschedl, R. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01986-07 · Cited by 56
HIF-2α mediates hypoxia-induced LIF expression in human colorectal cancer cells
Wu, L., Yu, H., Zhao, Y., Zhang, C., Wang, J., Yue, X., Yang, Q., & Hu, W. (2015) · Oncotarget · doi:10.18632/oncotarget.3017 · Cited by 52
Self-citationYoo, Y.-G., Christensen, J., & Huang, L. E. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2360 · Cited by 50
Bogaerts, E., Heindryckx, F., Vandewynckel, Y., van Grunsven, L. A., & Vlierberghe, H. V. (2014) · International Journal of Oncology · doi:10.3892/ijo.2014.2286 · Cited by 45
Zhang, Q., Xl, B., Ma, T., Chen, W., Liu, H., Hu, Q., Liang, C., Xf, X., Xz, Y., Zhi, X., et al. (2012) · Cited by 34
Skuli, N., & Simon, M. C. (2009) · Cell Cycle · doi:10.4161/cc.8.20.9618 · Cited by 27
KLF4 transcriptionally activates non-canonical WNT5A to control epithelial stratification
Tétreault, M.-P., Weinblatt, D., Shaverdashvili, K., Yang, Y., & Katz, J. P. (2016) · Scientific Reports · doi:10.1038/srep26130 · Cited by 27
Lee, S. H., Zhu, C.-F., Peng, Y., Johnson, D. T., Lehmann, L. W., & Sun, Z.-J. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.529727 · Cited by 26
Prognostic Significance of BCL9 Expression in Hepatocellular Carcinoma
Hyeon, J., Ahn, S., Lee, J. J., Song, D. H., & Park, C.-K. (2013) · Journal of Pathology and Translational Medicine · doi:10.4132/koreanjpathol.2013.47.2.130 · Cited by 21
Cited by
Park, T.-E., Mustafaoglu, N., Herland, A., Hasselkus, R., Mannix, R., FitzGerald, E. A., Prantil-Baun, R., Watters, A., Henry, O., Benz, M., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-10588-0 · Cited by 594
Cancer Stem Cells: The Architects of the Tumor Ecosystem
Prager, B. C., Xie, Q., Bao, S., & Rich, J. N. (2019) · Cell Stem Cell · doi:10.1016/j.stem.2018.12.009 · Cited by 587
Mechanisms of vasculogenic mimicry in hypoxic tumor microenvironments
Wei, X., Chen, Y., Jiang, X., Peng, M., Liu, Y., Mo, Y., Ren, D., Hua, Y., Yu, B., Zhou, Y., et al. (2021) · Molecular Cancer · doi:10.1186/s12943-020-01288-1 · Cited by 463
Role of Wnt/β-catenin signaling in hepatocellular carcinoma, pathogenesis, and clinical significance
Khalaf, A. M., Fuentes, D., Morshid, A. I., Burke, M. R., Kaseb, A. O., Hassan, M., Hazle, J. D., & Elsayes, K. M. (2018) · Journal of Hepatocellular Carcinoma · doi:10.2147/jhc.s156701 · Cited by 227
Signaling pathways in hepatocellular carcinoma
(2021) · Advances in Cancer Research · doi:10.1016/bs.acr.2020.10.002 · Cited by 165
Metadata
- Authors
- Xu, W., Zhou, W., Cheng, M., Wang, J., Liu, Z., He, S., Luo, X., Huang, W., Chen, T., Yan, W., & Xiao, J.
- Affiliations
- Second Military Medical University (CN)
- Xuzhou Medical College (CN)
- Fudan University (CN)
- Corresponding author
- Chen, Tianrui
- Yan, Wangjun
- Xiao, Jianru
- ORCID
- Venue
- Scientific Reports
- Published
- 2017-01-11
- Volume
- 7
- Issue
- 1
- Pages
- 40446-40446
- ISSN
- 2045-2322 (ISSN-L)
- PMC
- PMC5225427
- OpenAlex
- W2572807950
- Cited by
- 85
- References
- 51
- Citations by year
- 2026: 1 · 2025: 8 · 2024: 8 · 2023: 8 · 2022: 10 · 2021: 12 · 2020: 11 · 2019: 12 · 2018: 9 · 2017: 6
- FWCI
- 4.24
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Scientific Reports (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China (81572746, 81201556, 81372874)
- China Postdoctoral Science Foundation (43302)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Wnt/β-catenin signaling in development and cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Health Sciences › Medicine › Hepatology › Hepatocellular Carcinoma Treatment and Prognosis
- Keywords
- hepatocellular carcinoma, hypoxia, Wnt/β-catenin signaling, BCL9, HIF-1α, HIF-2α, tumor hypoxia, bone metastasis, tumor angiogenesis, cell proliferation and migration, signaling crosstalk
- MeSH terms
- Transcription Activator-Like Effector Nucleases, Endothelial PAS Domain-Containing Protein 1, Adult, Animals, Base Sequence, Bone Neoplasms, Cell Movement, Female, Genetic Engineering, Carcinoma, Hepatocellular, Humans, Liver Neoplasms, Male, Mice, Nude, Middle Aged, Neoplasm Proteins, Neovascularization, Pathologic, Promoter Regions, Genetic, Transcription Factors, Transcriptional Activation, Cell Hypoxia, Gene Expression Regulation, Neoplastic, Response Elements, Cell Proliferation, Basic Helix-Loop-Helix Proteins, Hypoxia-Inducible Factor 1, alpha Subunit, Hep G2 Cells, Wnt Signaling Pathway
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.